In BRCA2 mutation carriers, the cumulative breast cancer risk at the age of 80 years according to these data is increased up to 69% and for ovarian cancer up to 17%, respectively (Kuchenbaecker et al. 2017). This evidence concerns the gene BRCA2 and breast cancer.